Cladribine in the treatment of acute myeloid leukemia.
Department of Hematology, Medical University of Lodz, 93-510 Lodz, Ciołkowskiego 2, Poland. Electronic address: robaktad@csk.umed.lodz.pl.
Tadeusz
T
Robak
Department of Hematology, Medical University of Lodz, 93-510 Lodz, Ciołkowskiego 2, Poland.
Agnieszka
A
Wierzbowska
D000971:Antineoplastic Combined Chemotherapy Protocols; D001374:Azacitidine / Q000627:therapeutic use*; D017338:Cladribine; D003561:Cytarabine; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage
D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D017338:Cladribine; D008942:Mitoxantrone; D001374:Azacitidine; D000069585:Filgrastim
2-CdA; AML; Cladribine; Clofarabine; Induction; Refractory; Relapsed